Moderna has a slew of mRNA products in their pipeline for the future.
The pharmaceutical company is conducting clinical trials on mRNA ‘medicines’ for COVID + Flu, pediatric RSV, HIV, cancer, and many others.
Experimental mRNA technology won’t be exclusive to the disastrous COVID-19 shots.
Lots more mRNA in the pipeline
— Josh Stylman (@jstylman) May 6, 2022
Here’s a closer look:
One mRNA ‘therapeutic’ that sticks out is autoimmune hepatitis, considering the mysterious outbreak of hepatitis in children around the world.
Is it a coincidence recent studies found that the experimental COVID-19 shots can cause immune-mediated hepatitis?
Review Moderna’s pipeline of mRNA ‘medicines’ HERE and what clinical trial phase each is currently at.
Our product pipeline shows the progress we’re making on clinical programs currently in development to create mRNA medicines for a wide range of diseases and conditions. We are proud of the advancements we’ve made in pioneering new mRNA vaccines and treatments that may have the potential to treat and prevent rare diseases.